Stock Analysis

    Can H. Lundbeck A/S's (CPH:LUN) ROE Continue To Surpass The Industry Average?

    Source: Shutterstock

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. We'll use ROE to examine H. Lundbeck A/S (CPH:LUN), by way of a worked example.

    H. Lundbeck has a ROE of 22%, based on the last twelve months. That means that for every DKK1 worth of shareholders' equity, it generated DKK0.22 in profit.

    View our latest analysis for H. Lundbeck

    Advertisement

    How Do You Calculate ROE?

    The formula for return on equity is:

    Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

    Or for H. Lundbeck:

    22% = ø3.1b ÷ ø14b (Based on the trailing twelve months to September 2019.)

    It's easy to understand the 'net profit' part of that equation, but 'shareholders' equity' requires further explanation. It is all earnings retained by the company, plus any capital paid in by shareholders. The easiest way to calculate shareholders' equity is to subtract the company's total liabilities from the total assets.

    What Does Return On Equity Mean?

    ROE looks at the amount a company earns relative to the money it has kept within the business. The 'return' is the yearly profit. A higher profit will lead to a higher ROE. So, all else being equal, a high ROE is better than a low one. That means ROE can be used to compare two businesses.

    Does H. Lundbeck Have A Good Return On Equity?

    Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. Pleasingly, H. Lundbeck has a superior ROE than the average (9.7%) company in the Pharmaceuticals industry.

    CPSE:LUN Past Revenue and Net Income, January 23rd 2020
    CPSE:LUN Past Revenue and Net Income, January 23rd 2020

    That is a good sign. We think a high ROE, alone, is usually enough to justify further research into a company. For example, I often check if insiders have been buying shares.

    Why You Should Consider Debt When Looking At ROE

    Virtually all companies need money to invest in the business, to grow profits. That cash can come from issuing shares, retained earnings, or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. That will make the ROE look better than if no debt was used.

    Combining H. Lundbeck's Debt And Its 22% Return On Equity

    Although H. Lundbeck does use a little debt, its debt to equity ratio of just 0.048 is very low. Its ROE is very impressive, and given only modest debt, this suggests the business is high quality. Judicious use of debt to improve returns can certainly be a good thing, although it does elevate risk slightly and reduce future optionality.

    In Summary

    Return on equity is one way we can compare the business quality of different companies. In my book the highest quality companies have high return on equity, despite low debt. All else being equal, a higher ROE is better.

    But when a business is high quality, the market often bids it up to a price that reflects this. Profit growth rates, versus the expectations reflected in the price of the stock, are a particularly important to consider. So you might want to check this FREE visualization of analyst forecasts for the company.

    If you would prefer check out another company -- one with potentially superior financials -- then do not miss thisfree list of interesting companies, that have HIGH return on equity and low debt.

    If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

    We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.